Breast cancer research : BCR
Journal
Overview
publication venue for
-
Reproductive factors and mammographic density within the International Consortium of Mammographic Density: A cross-sectional study..
26.
2024
-
Impact of an online decision support tool for ductal carcinoma in situ (DCIS) using a pre-post design (AFT-25)..
26.
2024
-
A triple hormone receptor ER, AR, and VDR signature is a robust prognosis predictor in breast cancer..
26.
2024
-
Association of early menarche with breast tumor molecular features and recurrence..
26.
2024
-
TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer..
26.
2024
-
Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis..
25.
2023
-
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry..
25.
2023
-
Associations of alcohol consumption with breast tissue composition..
25.
2023
-
Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers..
25.
2023
-
Associations of aspirin and other anti-inflammatory medications with breast cancer risk by the status of COX-2 expression..
24.
2022
-
Association of body mass index and inflammatory dietary pattern with breast cancer pathologic and genomic immunophenotype in the nurses' health study..
24.
2022
-
A genome-wide association study of mammographic texture variation..
24.
2022
-
The association of age at menarche and adult height with mammographic density in the International Consortium of Mammographic Density..
24.
2022
-
CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcome..
24.
2022
-
Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci..
24.
2022
-
Common variants in breast cancer risk loci predispose to distinct tumor subtypes..
24.
2022
-
STAT5 is activated in macrophages by breast cancer cell-derived factors and regulates macrophage function in the tumor microenvironment..
23.
2021
-
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment..
23.
2021
-
Adolescent and early adulthood inflammation-associated dietary patterns in relation to premenopausal mammographic density..
23.
2021
-
Associations of reproductive breast cancer risk factors with breast tissue composition..
23.
2021
-
Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2- metastatic breast cancer in US real-world clinical practice..
23.
2021
-
Immune phenotype of patients with stage IV metastatic inflammatory breast cancer..
22.
2020
-
Hormonal determinants of mammographic density and density change..
22.
2020
-
Erythrocyte membrane fatty acids and breast cancer risk by tumor tissue expression of immuno-inflammatory markers and fatty acid synthase: a nested case-control study..
22.
2020
-
Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies..
22.
2020
-
Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer..
21.
2019
-
Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association..
21.
2019
-
Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk..
21.
2019
-
Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study..
21.
2019
-
Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype..
21.
2019
-
Genomic signature of parity in the breast of premenopausal women..
21.
2019
-
Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses' Health Studies..
21.
2019
-
Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98..
21.
2019
-
Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells..
21.
2019
-
Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study..
20.
2018
-
Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores..
20.
2018
-
Residential particulate matter and distance to roadways in relation to mammographic density: results from the Nurses' Health Studies..
19.
2017
-
Alcohol consumption and breast tumor gene expression..
19.
2017
-
A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer..
19.
2017
-
AKT1low quiescent cancer cells persist after neoadjuvant chemotherapy in triple negative breast cancer..
19.
2017
-
EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses' Health Studies..
19.
2017
-
Mammographic density assessed on paired raw and processed digital images and on paired screen-film and digital images across three mammography systems..
18.
2016
-
Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status..
18.
2016
-
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women..
18.
2016
-
Mammographic density and breast cancer risk: a mediation analysis..
18.
2016
-
Adolescent fiber intake and mammographic breast density in premenopausal women..
18.
2016
-
Clonal relationships between lobular carcinoma in situ and other breast malignancies..
18.
2016
-
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus..
18.
2016
-
Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas..
18.
2016
-
The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells..
18.
2016
-
Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer..
18.
2016
-
Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner..
18.
2016
-
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2..
18.
2016
-
Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer..
17.
2015
-
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers..
17.
2015
-
Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer..
17.
2015
-
Circulating tumor cells in newly diagnosed inflammatory breast cancer..
17.
2015
-
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers..
16.
2014
-
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia..
16.
2014
-
Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth..
16.
2014
-
Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial..
16.
2014
-
TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients..
16.
2014
-
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination..
16.
2014
-
Molecular effects of lapatinib in patients with HER2 positive ductal carcinoma in situ..
16.
2014
-
Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer..
16.
2014
-
Dickkopf-1 is regulated by the mevalonate pathway in breast cancer..
16.
2014
-
Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy..
15.
2013
-
A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors..
15.
2013
-
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype..
15.
2013
-
Spectral discrimination of breast pathologies in situ using spatial frequency domain imaging..
15.
2013
-
Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions..
14.
2012
-
Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II..
14.
2012
-
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers..
14.
2012
-
Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis..
13.
2011
-
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2..
13.
2011
-
Nondense mammographic area and risk of breast cancer..
13.
2011
-
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment..
13.
2011
-
Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation..
12.
2010
-
Mammary stem cells and cancer: roles of Wnt signaling in plain view..
12.
2010
-
Columnar cell lesions and subsequent breast cancer risk: a nested case-control study..
12.
2010
-
Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer..
12.
2010
-
The role of YY1 in reduced HP1alpha gene expression in invasive human breast cancer cells..
11.
2009
-
Immunohistochemical characterization of subtypes of male breast carcinoma..
11.
2009
-
How much can improved molecular and pathologic discriminants change local therapy?.
10 Suppl 4.
2008
-
Breast cancer susceptibility loci and mammographic density..
10.
2008
-
Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer..
10.
2008
-
Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study..
9.
2007
-
Role of human HGFIN/nmb in breast cancer..
9.
2007
-
Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer..
9.
2007
-
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers..
8.
2006
-
Single nucleotide polymorphisms and breast cancer: not yet a success story..
8.
2006
-
Benign breast disease, recent alcohol consumption, and risk of breast cancer: a nested case-control study..
7.
2005
-
Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies..
7.
2005
-
Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case-control study..
6.
2004
-
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment..
6.
2003
-
Retraction Note: Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy..
25.
2023
-
CYP2D6 genotype and tamoxifen response.
2005
-
Associations between dietary patterns and the risk of breast cancer: a systematic review and meta-analysis of observational studies.
2019
-
Epithelial-mesenchymal transition, cancer stem cells and treatment resistance.
2012
-
Local control by radiotherapy: is that all there is?
2008
-
Is there a role for Notch signalling in human breast cancer?
2003
-
The role of the ubiquitination-proteasome pathway in breast cancer: use of mouse models for analyzing ubiquitination processes.
2002
-
Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development.
2000
-
Molecular characterization and targeted therapeutic approaches in breast cancer.
2015
-
Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management.
2011
-
New targets for therapy in breast cancer: mammalian target of rapamycin (mTOR) antagonists.
2004
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)